SCHEMBL31451700

SCHEMBL31451700

CC(C)(C)OC(=O)N1C2CCC1CN(c1cc(OC[C@@]34CCCN3C[C@H](F)C4)nc(Cl)n1)C2

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 17/20 0.37
▸ RET P07949 2/20 0.35
▸ HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29151437 1.00 KRAS (0.37) KRASRETHDAC1
SCHEMBL31451806 0.88 KRAS (0.41) KRAS
SCHEMBL30949859 0.88 KRAS (0.41) KRAS
SCHEMBL31328546 0.84 KRAS (0.40) KRAS
SCHEMBL31328675 0.84 KRAS (0.40) KRAS
SCHEMBL29151485 0.84 KRAS (0.40) KRAS
SCHEMBL31328693 0.84 KRAS (0.40) KRAS
SCHEMBL31451752 0.81 KRAS (0.39) KRAS
SCHEMBL30957194 0.80 KRAS (0.41) KRAS
SCHEMBL29876081 0.80 KRAS (0.44) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025016899-A1 SPIROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER BAYER AKTIENGESELLSCHAFT (DE) 2025-01-23 — — WO disclosed
Send feedback